Nyxoah SA NYXH
0.81 USD 0.00 (-0.26%)
Nov 6, 2026, 2:29 PM EST
0.8001 Day range 0.83
0.80 52-week range 5.92
- YTD
- -82.42%
- 1 year
- -83.89%
News
benzinga.com Nyxoah Q3 2026 Earnings Call Transcript Nyxoah (NASDAQ:NYXH) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com Nyxoah Q3 EPS $(0.20) Beats $(0.24) Estimate, Sales $10.554M Miss $11.110M Estimate Nyxoah (NASDAQ:NYXH) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.24) by 16.67 percent. This is a 72.22 percent increase over losses of $(0.72) per…
benzinga.com Cantor Fitzgerald Maintains Overweight on Nyxoah, Lowers Price Target to $3 Cantor Fitzgerald analyst Sarah James maintains Nyxoah (NASDAQ:NYXH) with a Overweight and lowers the price target from $6 to $3.
benzinga.com Why RingCentral Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket RingCentral surged 15% after beating Q3 estimates and raising FY26 guidance; XXII, LABT and HUBC led premarket gainers, while LNAI fell.
benzinga.com Nyxoah Reports Preliminary Q3 Global Net Sales Of ~€9.2M, Up 19% QoQ; Lowers FY26 Global Net Sales From €36M-€40M To €33M-€35M Third Quarter 2026 – Preliminary Sales and Market MetricsFinancialsGlobal net revenue is expected to be approximately €9.2 million in the third quarter of 2026, which reflects 19% sequential growth…
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers Firefly Neuroscience (NASDAQ:AIFF) shares increased by 33.2% to $1.58 during Friday's regular session. The company's market cap stands at $18.6 million. Apimeds Pharmaceuticals (AMEX:APUS)…- benzinga.com Nyxoah Appoints Loic Moreau As Interim CFO, Effective Oct. 2, Succeeding John Landry; Reiterates FY26 Revenue Range Of €36M - €40M Nyxoah SA (Euronext Brussels/NASDAQ:NYXH) ("Nyxoah" or the "Company"), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through
benzinga.com Reported Earlier, Nyxoah Begins US Study Of Sleep Apnea Implant In First Patient Nyxoah SA (Euronext Brussels/NASDAQ:NYXH) ("Nyxoah" or the "Company"), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Gelteq (NASDAQ:GELS) shares increased by 38.6% to $0.97 during Thursday's pre-market session. The company's market cap stands at $7.4 million. bioAffinity Technologies (NASDAQ:BIAF) shares…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Gelteq (NASDAQ:GELS) stock moved upwards by 20.3% to $0.84 during Wednesday's after-market session. The company's market cap stands at $5.6 million. Nyxoah (NASDAQ:NYXH) shares increased by…
benzinga.com Nyxoah's ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse PatientsReports an Apnea-Hypopnea Index (AHI) responder rate of 77.2% on a Full…
benzinga.com Cantor Fitzgerald Maintains Overweight on Nyxoah, Lowers Price Target to $6 Cantor Fitzgerald analyst Sarah James maintains Nyxoah (NASDAQ:NYXH) with a Overweight and lowers the price target from $11 to $6.- benzinga.com Piper Sandler Reiterates Overweight on Nyxoah, Lowers Price Target to $6 Piper Sandler analyst Adam Maeder reiterates Nyxoah (NASDAQ:NYXH) with a Overweight and lowers the price target from $7 to $6.
- benzinga.com Nyxoah Lowers FY2026 Sales Guidance from $42.156M-$46.840M to $41.852M-$46.502M vs $44.410M Est Nyxoah (NASDAQ:NYXH) lowers FY2026 sales outlook from $42.156 million-$46.840 million to $41.852 million-$46.502 million vs $44.410 million estimate.
- benzinga.com Nyxoah Q2 EPS $(0.67) Misses $(0.47) Estimate, Sales $8.922M Miss $9.030M Estimate Nyxoah (NASDAQ:NYXH) reported quarterly losses of $(0.67) per share which missed the analyst consensus estimate of $(0.47) by 42.55 percent. This is a 8.06 percent decrease over losses of $(0.62) per…
- benzinga.com Nyxoah Reports Preliminary Q2 Global Net Revenue Of ~€7.7M, Reiterates FY26 Global Net Revenue Range €36M - €40M Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Seer (NASDAQ:SEER) shares rose 32.1% to $2.14 during Monday's pre-market session. The market value of their outstanding shares is at $89.0 million. Innovative Eyewear (NASDAQ:LUCY) stock rose…- benzinga.com Nyxoah Receives $15M Second Tranche Proceeds From Its Loan Facility With European Investment Bank Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"), a medical technology company focused on developing innovative solutions for Obstructive Sleep Apnea (OSA), today announced that…
benzinga.com Stifel Maintains Hold on Nyxoah, Lowers Price Target to $3 Stifel analyst Jonathan Block maintains Nyxoah (NASDAQ:NYXH) with a Hold and lowers the price target from $5 to $3.- benzinga.com Nyxoah Expects Receipt Of $15M Second Tranche Of $110M European Investment Bank Loan To Pursue Commercialization Of Genio In U.S. Markets Financing and Leadership Transition Highlights$110 million in new capital$95 million in equity financing with strong insider participation$15 million anticipated second tranche of its European…
benzinga.com What's Going On With Nyxoah Stock Tuesday? Nyxoah (NYXH) raises $95M via public offering to fund U.S. commercial growth and Genio system R&D. Stock ticks up in premarket.- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com Nyxoah Announces Underwritten Public Offering Of $95M Through Sale Of 55,232,558 Shares At A Price Of $1.72/Share Nyxoah Announces Pricing of $95 Million Underwritten Public OfferingMont-Saint-Guibert, Belgium – June 5, 2026, 5:25 pm CET / 11:25 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the…
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Why Solidion Technology Shares Are Rallying Over 50%; Here Are 20 Stocks Moving Premarket Solidion Technology, Inc. (NASDAQ: STI) rose 50.55% in pre-market trading on Friday after announcing their extreme-climate battery technology.- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com Nyxoah Commences Underwritten Public Offering; Terms Undisclosed Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"), a medical technology company focused on developing innovative solutions for Obstructive Sleep Apnea (OSA), today announced the…- benzinga.com Piper Sandler Reiterates Overweight on Nyxoah, Lowers Price Target to $7 Piper Sandler analyst Adam Maeder reiterates Nyxoah (NASDAQ:NYXH) with a Overweight and lowers the price target from $9 to $7.
- benzinga.com Nyxoah Reports Q1 2026 Results: Full Earnings Call Transcript
- benzinga.com Nyxoah Q1 EPS $(0.43) Beats $(0.54) Estimate, Sales $7.462M Beat $7.130M Estimate Nyxoah (NASDAQ:NYXH) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.54) by 20.37 percent. This is a 31.75 percent increase over losses of $(0.63) per…
benzinga.com This Toast Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday Wall Street analysts changed outlook on top names. Check rating changes on Benzinga's analyst ratings page. See what analysts think of TOST stock.
benzinga.com Earnings Scheduled For May 12, 2026 - benzinga.com Stifel Downgrades Nyxoah to Hold, Lowers Price Target to $5 Stifel analyst Jonathan Block downgrades Nyxoah (NASDAQ:NYXH) from Buy to Hold and lowers the price target from $8 to $5.
- benzinga.com Stifel Maintains Buy on Nyxoah, Lowers Price Target to $8 Stifel analyst Jonathan Block maintains Nyxoah (NASDAQ:NYXH) with a Buy and lowers the price target from $10 to $8.
- benzinga.com Cantor Fitzgerald Reiterates Overweight on Nyxoah, Maintains $11 Price Target Cantor Fitzgerald analyst Sarah James reiterates Nyxoah (NASDAQ:NYXH) with a Overweight and maintains $11 price target.
- benzinga.com Stifel Maintains Buy on Nyxoah, Lowers Price Target to $10 Stifel analyst Jonathan Block maintains Nyxoah (NASDAQ:NYXH) with a Buy and lowers the price target from $11 to $10.
- benzinga.com Nyxoah Q4 EPS $(0.68) Misses $(0.65) Estimate, Sales $6.570M Miss $6.740M Estimate Nyxoah (NASDAQ:NYXH) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.65) by 4.62 percent. This is a 38.78 percent decrease over losses of $(0.49) per…
- benzinga.com Earnings Scheduled For March 19, 2026
- benzinga.com Earnings Scheduled For November 13, 2025
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet - benzinga.com Earnings Scheduled For August 18, 2025
benzinga.com Why MongoDB Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket 
benzinga.com Earnings Scheduled For May 14, 2025 
benzinga.com Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - benzinga.com Earnings Scheduled For March 13, 2025
- benzinga.com Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.
benzinga.com CarMax Reports Downbeat Earnings, Joins Lovesac And Other Big Stocks Moving Lower In Thursday's Pre-Market Session U.S. stock futures were lower this morning, with the Dow futures falling over 150 points on Thursday.